Next, we sought to confirm whether these SSOs could restore dystrophin protein by inducing DMD exon 50 skipping in DMD model cells, human rhabdomyosarcoma cells with a DMD intron 50–57 deletion mutation induced by the CRISPR/Cas9 system [26]. The gene discussed is DMD; the disease is rhabdomyosarcoma.